Multivalent Polymers
|
||||
Product Name |
Product Number |
Unit Size |
Price (USD) As of 9/15/08 |
|
|---|---|---|---|---|
| HOCH2(HOCH)4CH2NH-PAA | 08-000 | 0.5 mg | 30.00 | |
Monosaccharides |
||||
| a-D-Glucose-PAA | 08-001 | 1 mg | 140.00 | |
| b-D-Glucose-PAA | 08-002 | 1 mg | |
|
| a-D-Galactose-PAA | 08-003 | 1 mg | |
|
| b-D-Galactose-PAA | 08-004 | 1 mg | |
|
| a-D-Mannose-PAA | 08-005 | 1 mg | |
|
| a-D-Man-6-phosphate-PAA | 08-006 | 1 mg | 190.00 | |
| a-L-Fucose-PAA | 08-007 | 1 mg | |
|
| a-L-Rhamnose-PAA | 08-008 | 1 mg | |
|
| b-GlcNAc-PAA | 08-009 | 1 mg | |
|
| a-GalNAc-PAA | 08-010 | 1 mg | |
|
| b-GalNAc-PAA | 08-011 | 1 mg | |
|
| a-Neu5Ac-PAA | 08-012 | 1 mg | 285.00 | |
| a-Neu5Ac-OCH2C6H4-p-NHCOCH2-PAA | 08-013 | 1 mg | |
|
| MDP-PAA | 08-014 | 1 mg | 265.00 | |
| b-D-Gal-3-sulfate-PAA | 08-015 | 1 mg | 190.00 | |
| b-D-GlcNAc-6-sulfate-PAA | 08-016 | 1 mg | 235.00 | |
| b-D-Man-PAA | 08-050 | 1 mg | 190.00 | |
| Neu5Gca-PAA | 08-051 | 1 mg | 320.00 | |
| 3-HSO3-GalNAcb-PAA | 08-104 | 1 mg | 190.00 | |
Disaccharides |
||||
| Blood type A: GalNAca1-3Galb-PAA | 08-017 | 1 mg | |
|
| Blood type B: Gala1-3Galb-PAA | 08-018 | 1 mg | |
|
| Blood type H: Fuca1-2Galb-PAA | 08-019 | 1 mg | |
|
| Galb1-3GlcNAcb-PAA (Lec-PAA) | 08-020 | 1 mg | 190.00 | |
| Galb1-4Glcb-PAA (Lac-PAA) | 08-021 | 1 mg | |
|
| Galb1-4GlcNAcb-PAA (LacNAc-PAA) | 08-022 | 1 mg | 235.00 | |
| Galb1-3GalNAca-PAA | 08-023 | 1 mg | 190.00 | |
| Fuca1-3GlcNAcb-PAA | 08-024 | 1 mg | |
|
| Fuca1-4GlcNAcb-PAA | 08-025 | 1 mg | |
|
| GalNAca1-3GalNAcb-PAA | 08-026 | 1 mg | |
|
| GalNAca1-3GalNAca-PAA | 08-027 | 1 mg | |
|
| Gala1-3GalNAca-PAA | 08-028 | 1 mg | |
|
| Galb1-3GalNAcb-PAA | 08-029 | 1 mg | |
|
| Gala1-3GalNAcb-PAA | 08-030 | 1 mg | |
|
| Galb1-3Galb-PAA | 08-031 | 1 mg | |
|
| GlcNAcb1-3Galb-PAA | 08-052 | 1 mg | 235.00 | |
| Gala1-4GlcNAcb-PAA, (a-LacNAc-PAA) | 08-053 | 1 mg | |
|
| Glca1-4Glcb-PAA (maltose) | 08-054 | 1 mg | 140.00 | |
| Galb1-3GalNAca-PAA, sp=-p-OC6H4- | 08-055 | 1 mg | |
|
| Gala1-2Galb-PAA | 08-056 | 1 mg | |
|
| GlcNAcb1-4GlcNAcb-PAA | 08-057 | 1 mg | |
|
| GlcNAcb1-4GlcNAcb-PAA, sp=-NHCOCH2NH- | 08-058 | 1 mg | |
|
| Neu5Aca2-6GalNAca-PAA | 08-059 | 0.5 mg | 430.00 | |
| H(type 3)-PAA | 08-060 | 1 mg | 320.00 | |
| 3`-HSO3LacNAc-PAA | 08-061 | 1 mg | |
|
| 3`-HSO3Galb-3GlcNAcb-PAA | 08-062 | 1 mg | |
|
| Gala1-6Glcb-PAA (melibiose) | 08-063 | 1 mg | 190.00 | |
| Neu5Aca2-8Neu5Aca-sp**-PAA, (Neu5Ac)2 | 08-064 | 1 mg | |
|
| Galb1-2Galb-PAA | 08-065 | 1 mg | 235.00 | |
| 6-HSO3Galb1-4GlcNAcb-PAA | 08-066 | 1 mg | |
|
| Neu5Aca2-3Gal-PAA | 08-067 | 1 mg | 320.00 | |
| 6`-HSO3Galb1-4GlcNAcb-PAA | 08-068 | 1 mg | |
|
| 3`-HSO3Galb1-3GalNAca-PAA | 08-069 | 1 mg | |
|
| GalNAcb1-3GalNAcb-PAA | 08-070 | 1 mg | 235.00 | |
| GlcNAcb1-3GalNAca-PAA | 08-071 | 1 mg | 190.00 | |
| GlcNAcb1-6GalNAca-PAA | 08-072 | 1 mg | 190.00 | |
| Neu5Aca2-6Galb-PAA | 08-105 | 0.5 mg | 380.00 | |
| Fucb1-3GlcNAcb-PAA | 08-106 | 1 mg | 370.00 | |
| Neu5Gca2-6GalNAca-PAA | 08-107 | 0.5 mg | 650.00 | |
| Neu5Acb2-6GalNAca-PAA | 08-108 | 0.5 mg | 43 |
|
| Neu5Aca2-3GalNAca-PAA | 08-109 | 0.5 mg | 430.00 | |
Trisaccharides |
||||
| Blood type A (tri)-PAA | 08-032 | 1 mg | 265.00 | |
| Blood type A (tri)-PAA, sp=(CH2)3NHCO(CH2)5NH- | 08-084 | 1 mg | |
|
| Blood type B (tri)-PAA | 08-033 | 1 mg | |
|
| Blood type B (tri)-PAA, sp=(CH2)3NHCO(CH2)5NH- | 08-085 | 1 mg | |
|
| H (type 2)-PAA | 08-034 | 1 mg | 320.00 | |
| Lea-PAA | 08-035 | 1 mg | |
|
| Lex-PAA | 08-036 | 1 mg | |
|
| Led (H type 1)-PAA | 08-037 | 1 mg | |
|
| 3'-Sialyllactose-PAA | 08-038 | 0.5 mg | 210.00 | |
| 6'-Sialyllactose-PAA | 08-039 | 0.5 mg | 550.00 | |
| 3'-HSO3Lea-PAA | 08-040 | 0.5 mg | |
|
| 3'-HSO3Lex-PAA | 08-041 | 0.5 mg | |
|
| Galb1-4Galb1-4Glcb-PAA | 08-073 | 1 mg | 265.00 | |
| GalNAcb1-4Galb1-4Glcb-PAA | 08-074 | 1 mg | |
|
| Gala1-3Galb1-4Glcb-PAA | 08-075 | 1 mg | |
|
| GlcNAcb1-2Galb1-3GalNAca-PAA | 08-076 | 1 mg | |
|
| Neu5Aca2-3Galb1-4GlcNAcb-PAA | 08-077 | 0.5 mg | |
|
| 3`SiaLec-PAA | 08-078 | 0.5 mg | |
|
| Gala1-3Galb1-4GlcNAcb-PAA | 08-079 | 1 mg | 320.00 | |
| GlcNAca1-3Galb1-3GalNAca-PAA | 08-080 | 1 mg | |
|
| Neu5Aca2-8Neu5Aca2-8Neu5Aca-sp**-PAA, (Neu5Ac)3 | 08-081 | 1 mg | |
|
| GlcNAcb1-3Galb1-3GalNAca-PAA | 08-082 | 1 mg | |
|
| Galb1-3(GlcNAcb1-6)GalNAca-PAA | 08-083 | 1 mg | |
|
| GlcNAcb1-3Galb1-4GlcNAcb-PAA | 08-086 | 1 mg | |
|
| GlcNAcb1-3Galb1-4Glcb-PAA | 08-087 | 1 mg | |
|
| Neu5Aca2-3Galb1-3GalNAca-PAA | 08-088 | 0.5 mg | 550.00 | |
| GlcNAcb1-3(GlcNAcb1-6)GalNAca-PAA | 08-089 | 1 mg | |
|
| Gala1-4Galb1-4GlcNAcb-PAA | 08-110 | 1 mg | 380.00 | |
| GlcNAc |
08-111 | 1 mg | 370.00 | |
| GlcNAc |
08-112 | 1 mg | 290.00 | |
| Gal |
08-113 | 0.5 mg | 430.00 | |
| Gal |
08-114 | 0.5 mg | 265.00 | |
| Neu5Aca2-3(Neu5Aca2-6)GalNAca-PAA | 08-115 | 0.5 mg | 585.00 | |
| Gal |
08-116 | 1 mg | 380.00 | |
| Gal |
08-117 | 1 mg | |
|
Tetra- and more Oligosaccharides |
||||
| Leb-PAA | 08-042 | 1 mg | 320.00 | |
| Ley-PAA | 08-043 | 1 mg | 410.00 | |
| Sialyl Lea-PAA | 08-044 | 0.5 mg | 550.00 | |
| Sialyl Lex-PAA | 08-045 | 0.5 mg | 550.00 | |
| GlcNAcb1-3(GlcNAcb1-6)Gal�1-4Glcb-PAA | 08-090 | 1 mg | 265.00 | |
| GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-091 | 1 mg | 550.00 | |
| Gala1-3(Fuca1-2)Galb1-4GlcNAcb-PAA | 08-092 | 1 mg | |
|
| Gala1-3Galb1-4 |
08-093 | 1 mg | |
|
| Neu5Aca2-3(6-HSO3)Galb1-4(Fuca1-3)GlcNAcb-PAA (6Gal-HSO3-SiaLex) | 08-094 | 0.25 mg | |
|
| Neu5Aca2-3Galb1-4(Fuca1-3)(6-HSO3)GlcNAcb-PAA (6GlcNAc-HSO3-SiaLex) | 08-095 | 0.25 mg | |
|
| Galb1-3GlcNAcb1-3Galb1-4GlcNAcb-PAA | 08-096 | 0.5 mg | 370.00 | |
| Galb1-3GlcNAcb1-3Galb1-4Glcb-PAA | 08-097 | 0.5 mg | 320.00 | |
| Galb1-4GlcNAcb1-3Galb1-4Glcb-PAA | 08-098 | 0.5 mg | |
|
| |
08-100 | 1 mg | 265.00 | |
| Gal |
08-118 | 1 mg | 370.00 | |
| GalNAc |
08-119 | 1 mg | 370.00 | |
| GalNAc |
08-120 | 1 mg |
|
|
| Gal |
08-121 | 1 mg |
|
|
| GlcNAc |
08-122 | 1 mg |
|
|
| Gal |
08-123 | 1 mg | 380.00 | |
| Fuc |
08-124 | 1 mg |
|
|
| Gal |
08-125 | 1 mg | 380.00 | |
|
(SA2-6G-GN-M) (sp=-NHCOCH2NH-) SA=Neu5Ac, G= |
08-126 | 0.5 mg | 585.00 | |
Copyright � 1996-2008 by GlycoTech Corporation. All rights reserved.